EVIO, Inc. (OTCQB: EVIO) today announced that it has been granted an expansion to its accreditations from the Oregon Environmental Laboratory Accreditation Program.
EVIO, Inc. (OTCQB: EVIO) today announced that it has been granted an expansion to its accreditations from the Oregon Environmental Laboratory Accreditation Program.
Proposed Regulations Create Framework for Vibrant Market with Exceptional Growth Prospects
WeedMD announces that it has entered into a definitive lease and purchase option agreement with Perfect Pick Farms Ltd., a large-scale modern greenhouse cultivator located in Strathroy, Ontario.
Harvest One Cannabis Inc. (TSX VENTURE:HVST) announces that is has entered into an agreement with Mackie Research Capital Corporation (as the lead underwriter and sole bookrunner), on behalf of a syndicate of Underwriters pursuant to which the Underwriters have agreed to purchase, on a bought deal basis and sell to the public, 15,000 convertible debenture units of the Company at a price of $1,000 per Debenture Unit for aggregate gross proceeds of $15,000,000.
With growing trends toward legalization of medical and recreational use of marijuana, Medical Cannabis Payment Solutions (OTC: REFG) will provide a first-in-market digital payment solution for dispensaries.
A new report from market analyst the Brightfield Group, featured in Forbes, estimates that global sales of cannabis will climb to $31.4 billion by 2021.
India Globalization Capital, Inc. (NYSE American: IGC) sees opportunities in 2018, primarily from the distribution, in Germany, of its cannabinoid-based therapies, including IGC-AD1 (Hyalolex).
Through exacting scientific protocols, Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP) is about to radically change the understanding and applications of this millennia-old medicine.
Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) has pioneered an enabling technology that enhances the body’s absorption of cannabinoids.
PotNetwork Holding, Inc. (OTC: POTN), through wholly-owned subsidiary Diamond CBD, Inc., this morning reported revenues exceeding $1.6 million for the month of November.
On September 13, 2017, Cannevert Therapeutics Ltd. (“CTL”), the research arm of Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP), filed a provisional patent for the use of a specific strain of cannabis to enhance the actions of opioid analgesics.
Marijuana Company of America, Inc. (OTC: MCOA), via its wholly-owned subsidiary hempSMART, is well positioned to take advantage of this industry growth through the development and marketing of innovative hemp-derived, CBD-based nutritional and wellness products.
In Canada, chronic pain affects 1.5 million people. As national and worldwide numbers in pain diagnoses continue to rise, innovators in the cannabis industry are developing promising therapies to address this growing market.
One area of the industry that appears to offer significant growth potential is the application of bitcoin and other cryptocurrencies to sectors of the economy, such as the cannabis industry.
Research and development company Skinvisible Pharmaceuticals, Inc. (OTCQB: SKVI), continues to add significant value to its core business model with several key movements involving a proposed merger, new licensing agreements and formation of a specialized subsidiary.